Status:
TERMINATED
Alternate Day vs. Daily Iron Supplementation in Iron Depleted Women in the Philippines
Lead Sponsor:
Swiss Federal Institute of Technology
Collaborating Sponsors:
St. Luke's Medical Center
University of Oxford
Conditions:
Iron-deficiency
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Iron is very important for our body and performs vital tasks. Iron deficiency is a worldwide health problem. The prevalence of anemia in women of reproductive age in Southeast Asia is estimated to be ...
Eligibility Criteria
Inclusion
- Female, 18 to 45 years old,
- SF levels \<25 µg/L,
- Hb levels 11-15.5 g/dL
- Normal Body Mass Index (18.5-25 kg/m2),
- In possession of a mobile phone on which the study app can be loaded
- Signed informed consent
Exclusion
- Elevated CRP \> 5 mg/L
- Any metabolic, gastrointestinal, kidney or chronic disease such as diabetes, renal failure, hepatic dysfunction, hepatitis, hypertension, cancer or cardiovascular diseases (according to the participants own statement) affecting iron metabolism,
- Use of medication which may interfere with iron absorption, gut physiology and iron metabolism
- Consumption of iron supplements within 2 weeks prior to study start and of additional iron supplements during the study period
- Difficulties with blood sampling,
- Known hypersensitivity or allergy to iron or placebo capsules in the given amount (ferrous sulfate, mannitol, silica)
- Pregnancy, breastfeeding
- Known or suspected non-compliance, drug or alcohol abuse
- Cigarette smokers
Key Trial Info
Start Date :
April 6 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 19 2022
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT05280821
Start Date
April 6 2022
End Date
November 19 2022
Last Update
January 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Santo Tomas Hospital
Manila, National Capital Region, Philippines, 1015